|
Re: Risk of Recurrent Disease in HER2-Positive Patients
Hi Tricia,
I will reach out to him and ask him.
My onc. here on the East coast has advised strongly to stay on the AI. I have thought for a while that an
herceptin boost would be ideal...even if off label.
Let's see what he says.
Sending best wishes to all.
jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
|
Hybrid Mode
